Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma

Clinical trial NCT06396481 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06396481
Sponsor: Beijing Tiantan Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

GBM DIPG Brain Tumor Medulloblastoma

Start date: 2024-04-30
Primary completion: 2026-12-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.